Brevan Howard Capital Management LP Vir Biotechnology, Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 20,633 shares of VIR stock, worth $113,481. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,633Holding current value
$113,481% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding VIR
# of Institutions
233Shares Held
90.1MCall Options Held
1.28MPut Options Held
235K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$91.8 Million1.08% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$90.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$72.2 Million0.0% of portfolio
-
State Street Corp Boston, MA5.07MShares$27.9 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.22MShares$17.7 Million0.64% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $730M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...